Skip to main content

Table 2 Characteristics of the responders who were dispensed R03 medications according to their diagnoses

From: Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland

 

Asthma

Asthma and COPD

COPD

No obstructive airway disease

Overall p value

Post hoc p value < 0.05

Totala

495(61.6)

46(5.7)

41(5.1)

221(27.5)

n/a

n/a

Femalesb

313(63.2)

20(43.5)

10(24.4)

149(67.4)

 < 0.001

p < 0.05 for

A and C

C and No Dg

A & C and No Dg

Agec Years

61(49–70)

64(60–70)

69(65–76)

60(49–68)

 < 0.001

p < 0.05 for

C and No Dg

A and C

A & C and No Dg

BMIc kg/m2

27.5 (24.4–31.2)

26.7 (23.8–30.7)

28.4 (22.9–31.9)

27.1(24.5–31.6)

0.741

 

Smoking statusd,b

    

 < 0.001

n/a

 Current

53 (10.7)

21 (45,7)

15 (36.6)

31 (14.4)

  

 Former

157 (31.7)

20 (43.5)

25 (61.0)

67 (31.0)

  

 Never

285 (57.6)

5 (10.9)

1 (2.4)

118 (54.6)

  
  1. Asthma (A), COPD (C), Asthma and COPD (A & C), no obstructive airway disease (No Dg)
  2. aN (% of the corrected total sample)
  3. bN (% within the DG Group)
  4. cMedian with IQR
  5. dSubjects with complete answers regarding smoking habits